| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti
Clin Mol Hepatol.2019;25(1):30-36.   Published online January 23, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0061
                              
Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
Soon Young Ko, Won Hyeok Choe
Clin Mol Hepatol.2018;24(4):351-357.   Published online March 16, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0063
                              
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.2018;24(3):169-229.   Published online August 10, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1004
                                 Cited By 2
Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals
Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano, Daniela Foti, Elio Gulletta, Carlo Torti
Clin Mol Hepatol.2018;24(2):151-162.   Published online April 24, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0059
                                 Cited By 2
Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study
Kwang Il Seo, Byung Chul Yun, Weiquan James Li, Sang Uk Lee, Byung Hoon Han, Eun Taek Park
Clin Mol Hepatol.2017;23(1):74-79.   Published online March 3, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0052
                                 Cited By 2
Management of direct antiviral agent failures
María Buti, Rafael Esteban
Clin Mol Hepatol.2016;22(4):432-438.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0107
                                 Cited By 15
The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
Ioannis Varbobitis, George V. Papatheodoridis
Clin Mol Hepatol.2016;22(3):319-326.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0045
                                 Cited By 24
Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
Hee Chul Nam, Hae Lim Lee, Hyun Yang, Myeong Jun Song
Clin Mol Hepatol.2016;22(2):259-266.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0020
                                 Cited By 6
Chronic hepatitis B in pregnancy: unique challenges and opportunities
Kumaresan Yogeswaran, Scott K. Fung
Korean J Hepatol.2011;17(1):1-8.   Published online March 21, 2011     
DOI: https://doi.org/10.3350/kjhep.2011.17.1.1
                                 Cited By 14
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
Tommaso Lorenzo Parigi, Maria Corina Plaz Torres, Alessio Aghemo
Received February 9, 2019     Accepted February 18, 2019     Published online May 2, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0022    
[Epub ahead of print]
                              
1 |
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 377
TOTAL : 230832